Anti Tissue Transglutaminase IgG at Test Zone Diagnostic Center

Anti Tissue Transglutaminase IgG at Test Zone Diagnostic Center

The Anti Tissue Transglutaminase IgG (tTG IgG) test is a highly specialized serological investigation performed at Test Zone Diagnostic Center to aid in the diagnosis and monitoring of celiac disease and other gluten-sensitive enteropathies. Tissue transglutaminase is a calcium-dependent enzyme found abundantly in the lamina propria of the small intestine, where it plays a critical role in the deamidation of gliadin peptides derived from dietary gluten. In individuals with a genetic predisposition (specifically carrying the HLA-DQ2 or HLA-DQ8 human leukocyte antigen alleles), the ingestion of gluten triggers an abnormal, T-cell-mediated autoimmune response. This response leads to the production of autoantibodies directed against tissue transglutaminase. While the IgA isotype of the anti-tTG antibody is the primary screening tool due to its high sensitivity and specificity, the IgG isotype (tTG IgG) is of paramount clinical importance, particularly in patients with selective IgA deficiency—a condition that is statistically ten to fifteen times more common in celiac disease patients than in the general population. By measuring the quantitative levels of IgG antibodies against tissue transglutaminase in the blood, clinicians at Test Zone Diagnostic Center can accurately identify celiac disease even when IgA-based tests yield false-negative results.

This laboratory evaluation is conducted using state-of-the-art Enzyme-Linked Immunosorbent Assay (ELISA) or Chemiluminescent Immunoassay (CLIA) technologies, ensuring the highest standards of analytical sensitivity and specificity. The primary anatomical structure evaluated indirectly through this serological marker is the small intestine, specifically the duodenum and jejunum. In active celiac disease, the autoimmune cascade causes progressive damage to the mucosal lining, characterized histologically by intraepithelial lymphocytosis, crypt hyperplasia, and varying degrees of villous atrophy. This structural degradation severely compromises the absorptive surface area of the gut, leading to the classic malabsorptive syndrome. The diagnostic value of the Anti Tissue Transglutaminase IgG test lies in its ability to provide a non-invasive, highly reliable indicator of this underlying mucosal damage. It serves as a crucial bridge in the diagnostic pathway, helping to determine whether a patient requires a confirmatory small bowel biopsy, which remains the diagnostic gold standard. Furthermore, the test is invaluable for monitoring dietary compliance and mucosal healing in patients already diagnosed with celiac disease who are undergoing treatment with a strict, lifelong gluten-free diet.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the clinical accuracy and diagnostic utility of the Anti Tissue Transglutaminase IgG test at Test Zone Diagnostic Center, patients must strictly adhere to specific preparation guidelines. The most critical requirement is the maintenance of a regular, gluten-containing diet prior to blood collection. Because the production of tTG IgG antibodies is directly stimulated by the ingestion of gluten, initiating a gluten-free diet before the test can cause antibody levels to decline rapidly, potentially leading to a false-negative result. Patients are generally advised to consume at least one meal containing gluten (such as wheat bread, pasta, or cereals) daily for a minimum of six to eight weeks leading up to the blood draw. If a patient has already transitioned to a gluten-free diet, a gluten challenge under the supervision of a gastroenterologist may be necessary before testing. There are no strict fasting requirements for this test, meaning patients can eat and drink normally on the day of the procedure, provided they remain well-hydrated. However, patients should inform the laboratory staff of any immunosuppressive medications, corticosteroids, or biotin supplements they are currently taking, as these substances can potentially interfere with antibody production or the immunoassay detection system.

During the Procedure

The collection of the blood sample for the Anti Tissue Transglutaminase IgG test at Test Zone Diagnostic Center is a routine, safe, and minimally invasive venipuncture procedure performed by highly trained phlebotomists. Upon arrival at the diagnostic facility, the patient is comfortably seated, and their identity is verified along with the specific test requisition. The phlebotomist carefully inspects the patient’s arm, typically selecting a prominent vein in the antecubital fossa (the crease of the elbow). The chosen site is thoroughly cleansed with an antiseptic solution, such as 70% isopropyl alcohol, and allowed to air dry to prevent hemolysis of the sample and minimize the risk of infection. A sterile tourniquet is applied a few inches above the venipuncture site to temporarily restrict venous blood flow, making the vein more visible and accessible. A single-use, sterile needle attached to a vacuum collection tube (typically a serum separator tube with a gold or red top) is gently inserted into the vein. The required volume of blood is drawn smoothly into the tube, after which the tourniquet is released, and the needle is carefully withdrawn. Immediate pressure is applied to the puncture site with a sterile gauze pad to promote hemostasis, and a protective adhesive bandage is applied. The entire collection process takes less than five minutes, with minimal discomfort described as a brief pinching sensation. The labeled specimen is then transferred to the immunology laboratory, where it undergoes centrifugation to separate the serum from the cellular components of the blood, followed by precise quantitative analysis using advanced automated analyzers.

When is a Anti Tissue Transglutaminase IgG Performed?

Screening for Celiac Disease in Patients with Selective IgA Deficiency

The primary clinical indication for performing the Anti Tissue Transglutaminase IgG test is the screening and diagnosis of celiac disease in individuals suspected of having selective IgA deficiency. Selective IgA deficiency is an immunodeficiency characterized by an undetectable level of serum immunoglobulin A (IgA) in the presence of normal IgG and IgM levels. Because standard celiac screening relies heavily on the anti-tTG IgA antibody, patients with this concurrent immunodeficiency will produce false-negative IgA results despite having active, severe celiac disease. In such clinical scenarios, measuring the IgG isotype of the anti-tissue transglutaminase antibody is medically imperative. Gastroenterologists and physicians routinely order a total serum IgA test alongside celiac serology; if the total IgA is found to be below the lower limit of normal, the Anti Tissue Transglutaminase IgG test is automatically utilized as the primary serological marker to ensure an accurate and reliable diagnostic assessment.

Investigation of Chronic Gastrointestinal Symptoms

Physicians frequently request the Anti Tissue Transglutaminase IgG test when evaluating patients presenting with chronic, unexplained gastrointestinal symptoms that suggest malabsorption or intestinal inflammation. These symptoms include persistent or intermittent chronic diarrhea, steatorrhea (foul-smelling, pale, bulky stools containing excess fat), recurrent abdominal pain, cramping, bloating, flatulence, and nausea. These clinical signs are indicative of chronic enteropathy and mucosal damage within the small intestine. By assessing the levels of tTG IgG, clinicians can differentiate celiac disease from other common gastrointestinal disorders with overlapping symptoms, such as Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD) including Crohn’s disease, small intestinal bacterial overgrowth (SIBO), or food intolerances, thereby guiding appropriate therapeutic interventions.

Assessment of Malabsorption and Unexplained Weight Loss

Unexplained weight loss and clinical signs of nutrient malabsorption are strong indications for the Anti Tissue Transglutaminase IgG test. When the small intestinal villi are damaged by the autoimmune response in celiac disease, the body’s ability to absorb essential macronutrients and micronutrients is severely compromised. This can manifest as refractory iron deficiency anemia (anemia that does not respond to oral iron supplementation), vitamin D and calcium malabsorption leading to early-onset osteopenia or osteoporosis, vitamin B12 deficiency, and unexplained weight loss despite adequate dietary intake. In pediatric patients, this malabsorptive state often presents as failure to thrive, short stature, delayed puberty, and significant developmental delays. The tTG IgG test helps identify whether an underlying gluten-sensitive enteropathy is the root cause of these systemic nutritional deficiencies.

Evaluation of Extraintestinal Manifestations of Gluten Sensitivity

Celiac disease is a systemic autoimmune disorder that can affect multiple organ systems beyond the gastrointestinal tract. Consequently, the Anti Tissue Transglutaminase IgG test is performed when patients exhibit classic extraintestinal manifestations of gluten sensitivity. One of the most prominent manifestations is Dermatitis Herpetiformis, an intensely itchy, blistering skin rash that typically appears symmetrically on the elbows, knees, buttocks, and scalp, and is histologically characterized by IgA/IgG deposits in the dermal papillae. Other extraintestinal indications include unexplained elevations in liver transaminases (celiac hepatitis), recurrent aphthous stomatitis (mouth ulcers), peripheral neuropathy, cerebellar ataxia, joint pain, chronic fatigue, and unexplained reproductive issues such as recurrent miscarriages or unexplained infertility. Identifying elevated tTG IgG levels in these patients confirms the systemic autoimmune nature of their symptoms.

Monitoring Adherence and Response to a Gluten-Free Diet

For patients with a confirmed diagnosis of celiac disease, the Anti Tissue Transglutaminase IgG test is an invaluable tool for long-term clinical monitoring. Following the initiation of a strict, lifelong gluten-free diet, the autoimmune stimulus is removed, and the levels of circulating tTG IgG antibodies should gradually decline over several months, eventually returning to the normal reference range. Clinicians at Test Zone Diagnostic Center perform serial measurements of tTG IgG at regular intervals (typically 6 months and 12 months post-diagnosis, and annually thereafter) to assess dietary compliance, detect accidental gluten exposure, and monitor mucosal healing. A persistent elevation or a sudden rise in tTG IgG titers indicates ongoing gluten ingestion, whether intentional or accidental due to cross-contamination, or, in rare cases, the development of refractory celiac disease.

What Does a Anti Tissue Transglutaminase IgG Detect?

The Anti Tissue Transglutaminase IgG test is designed to detect and quantify the concentration of IgG-class autoantibodies directed against the tissue transglutaminase enzyme in human serum. The clinical findings and interpretations derived from this test are highly specific to the patient’s immunological state and dietary habits. Specifically, the test detects: 1. Normal or negative levels of tTG IgG, indicating the absence of an active autoimmune response against the small intestinal mucosa. 2. Elevated or positive levels of tTG IgG, strongly suggesting active celiac disease or gluten-sensitive enteropathy. 3. Borderline or equivocal antibody levels, which require clinical correlation and potential retesting. 4. Serological evidence of celiac disease in patients with confirmed selective IgA deficiency. 5. Dietary non-compliance or accidental gluten exposure in diagnosed celiac patients. 6. Successful response to a gluten-free diet, demonstrated by a significant reduction in antibody titers over time. 7. Refractory celiac disease, characterized by persistently high antibody levels despite strict dietary restriction. 8. Potential cross-reactivity or non-specific immune activation associated with other autoimmune conditions, such as Type 1 Diabetes Mellitus. 9. Autoimmune activity associated with Hashimoto’s thyroiditis or Graves’ disease, which frequently co-occur with celiac disease. 10. Immunological markers consistent with Dermatitis Herpetiformis. 11. Silent or asymptomatic celiac disease in high-risk populations, including individuals with Down syndrome or Turner syndrome. 12. Familial predisposition and active disease in first-degree relatives of diagnosed celiac patients. 13. Serological correlation with Marsh Stage 1 mucosal damage (increased intraepithelial lymphocytes). 14. Serological correlation with Marsh Stage 2 mucosal damage (crypt hyperplasia). 15. Serological correlation with Marsh Stage 3 mucosal damage (partial, subtotal, or total villous atrophy). 16. Potential false-negative results in patients who have already initiated a gluten-free diet prior to testing. 17. False-negative results in patients undergoing immunosuppressive therapy or taking high-dose corticosteroids. 18. Elevated IgG levels associated with autoimmune hepatitis or other chronic liver diseases. 19. Immune responses in pediatric patients presenting with atypical extraintestinal symptoms. 20. Serological resolution and mucosal healing, indicated by the normalization of tTG IgG titers to baseline levels.

Turnaround Time and Report Access at Test Zone Diagnostic Center

At Test Zone Diagnostic Center, we understand the anxiety and clinical urgency associated with diagnostic testing. The Anti Tissue Transglutaminase IgG test is processed in our advanced immunology department using automated, high-throughput immunoassay systems that guarantee both speed and precision. The standard turnaround time for this specialized serological test is typically 24 to 48 hours from the time of sample collection. Once the analysis is complete, the results undergo a rigorous multi-level verification process by our consultant pathologists to ensure absolute accuracy. Patients and referring physicians are immediately notified via SMS or WhatsApp when the report is finalized. Reports can be accessed and downloaded digitally through the secure online patient portal on the official Test Zone Diagnostic Center website. Additionally, patients have the option to receive their printed reports directly from any of our convenient collection centers or have them delivered via our dedicated home delivery service, ensuring a seamless and patient-centric experience.

Anti Tissue Transglutaminase IgG Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
tTG IgG Antibody Level	< 10 U/mL (Negative)	≥ 15 U/mL (Positive, indicating active celiac disease or gluten sensitivity)
Total Serum IgA Level	Within age-adjusted reference range	< 0.2 g/L (Selective IgA deficiency, necessitating IgG-based testing)
Small Intestinal Villi (Inferred)	Normal villous height-to-crypt depth ratio, intact brush border	Blunted or completely flat villi (villous atrophy), crypt hyperplasia
Nutrient Absorption Capacity	Optimal absorption of iron, folate, B12, fat-soluble vitamins	Malabsorption leading to anemia, osteopenia, and nutritional deficiencies
Intraepithelial Lymphocytes	Normal levels (<25 IELs per 100 enterocytes)	Increased intraepithelial lymphocytosis (>25 IELs per 100 enterocytes)
Cutaneous Manifestations	Healthy skin, no unexplained vesicular rashes	IgA/IgG deposition in dermal papillae (Dermatitis Herpetiformis)
Dietary Compliance Status	Undetectable or declining antibody levels	Persistently elevated tTG IgG levels indicating accidental or deliberate gluten ingestion
Liver Transaminases (Co-evaluation)	Normal AST and ALT levels	Mildly elevated transaminases (celiac hepatitis) resolving on a gluten-free diet

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Test Zone Diagnostic Center for Anti Tissue Transglutaminase IgG?

• Experienced healthcare professionals and consultant pathologists overseeing all immunological assays.
• Patient-focused care designed to provide a comfortable, stress-free diagnostic experience.
• Quality diagnostic services utilizing state-of-the-art, automated ELISA and CLIA analyzers.
• Professional reporting with multi-level verification to ensure absolute clinical accuracy.
• Modern diagnostic approach incorporating international guidelines for celiac disease screening.
• Comfortable environment at all collection centers with strict adherence to hygiene and safety protocols.
• Convenient location and extensive network of collection points across the region.
• Commitment to accurate diagnosis with rapid turnaround times and secure online report access.